A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
Phase 4
Completed
- Conditions
- Dry Eye
- Registration Number
- NCT00399230
- Lead Sponsor
- Innovative Medical
- Brief Summary
To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
-
· Dry eye disease diagnosis
- Patients must currently be using Systane tears at least once a day and for at least 1 month.
- Normal lid position and closure
- Male or female of legal age of consent
- Informed consent has been obtained
- Likely to complete all required follow-up visits
Exclusion Criteria
-
· Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.
- Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Dr. Rajpal
🇺🇸McLean, Virginia, United States